Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Callens, Steven F J ^a   Kitetele, Faustin ^b   Lusiama, Jean ^b   Shabani, Nicole ^b   Edidi, Samuel ^c   Colebunders, Robert ^d   Behets, Frieda ^a   Van Rie, Annelies ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF KINSHASA   (Congo)

^c National AIDS Reference Laboratory   (Congo)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4 LYMPHOCYTE PERCENTAGE; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG INDICATION; FLOW CYTOMETRY; HEALTH CARE ACCESS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPPA STATISTICS; LEUKOCYTE COUNT; LINEAR REGRESSION ANALYSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PATIENT SELECTION; STAGING; AGE; BLOOD; CROSS-SECTIONAL STUDY; DECISION SUPPORT SYSTEM; DEMOCRATIC REPUBLIC CONGO; EVALUATION; IMMUNOLOGY; INFANT; INSTRUMENTATION; METHODOLOGY; NEWBORN; POVERTY; PRACTICE GUIDELINE; PRESCHOOL CHILD; STATISTICAL MODEL; WORLD HEALTH ORGANIZATION;

AGE FACTORS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; DEMOCRATIC REPUBLIC OF THE CONGO; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LINEAR MODELS; LYMPHOCYTE COUNT; POVERTY; PRACTICE GUIDELINES AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 42149104503     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-31     Document Type: Article

References (20)

1. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: Towards universal access. Recommendations for a public health approach http://www.who.int/hiv/pub/guidelines/ paediatric020907.pdf
2. Walker AS Mulenga V Sinyinza F Lishimpi K Nunn A Chintu C Gibb DM Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial J Acquir Immune Defic Syndr 2006, 42(5):637-645. 10.1097/01.qai.0000226334.34717.dc 16868501
3. HIV Paediatric Prognostic Markers Collaborative Study Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: A meta-analysis of longitudinal data Lancet 2005, 366(9500):1868-1874. 10.1016/S0140-6736(05)67757-4 16310553
4. Bachou H Tylleskar T Downing R Tumwine JK Severe malnutrition with and without HIV-1 infection in hospitalised children in Kampala, Uganda: differences in clinical features, haematological findings and CD4+ cell count Nutr J 2006, 5(1):27. 10.1186/1475-2891-5-27 17042940 1635055
5. Lugada ES Mermin J Kaharuza F Ulvestad E Were W Langeland N Asjo B Malamba S Downing R Population-based hematologic and immunologic reference values for a healthy Ugandan population Clin Diagn Lab Immunol 2004, 11(1):29-34. 10.1128/CDLI.11.1.29-34.2004 14715541 321349
6. Embree J Bwayo J Nagelkerke N Njenga S Nyange P Ndinya-Achola J Pamba H Plummer F Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi Pediatr Infect Dis J 2001, 20(4):397-403. 10.1097/00006454-200104000-00006 11332664
7. Landis JR Koch GG The measurement of observer agreement for categorical data Biometrics 1977, 33(1):159-174. 10.2307/2529310 843571
8. Freeman JV Cole TJ Chinn S Jones PR White EM Preece MA Cross sectional stature and weight reference curves for the UK, 1990 Arch Dis Child 1995, 73(1):17-24. 7639543
9. Sengoba J Awori M Blackham J Sims R Why are children still dying? [CDB0053] Presented at: XVI International AIDS Conference: 2006; Toronto, Canada 2006
10. Pierre R Steel-Duncan J Evans-Gilbert T Rodriguez B Moore J Palmer P Smikle M Davis D Figueroa J Christie C Effectiveness of interventions in treating paediatric HIV/AIDS in Jamaican children [CDB1017] Presented at: XVI International AIDS Conference: 2006; Toronto, Canada 2006.
11. Kaufmann GR Perrin L Pantaleo G Opravil M Furrer H Telenti A Hirschel B Ledergerber B Vernazza P Bernasconi E CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: The Swiss HIV Cohort Study Arch Intern Med 2003, 163(18):2187-2195. 10.1001/archinte.163.18.2187 14557216
12. Resino S Correa R Bellon JM Sanchez-Ramon S Munoz-Fernandez MA Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS AIDS Res Hum Retroviruses 2002, 18(18):1395-1406. 10.1089/088922202320935474 12487811
13. Johnson OO Benjamin DK Jr Schimana W Benjamin DK Landman K Tillekeratne LG Crump JA Kinabo GD Swai M Shao JF Absolute lymphocyte count and WHO pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among HIV-infected children in northern Tanzania [MOPE0100] Presented at: XVI International AIDS Conference: 2006; Toronto, Canada 2006.
14. Lynen L Teav S Vereecken C De Munter P An S Jacques G Kestens L Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia J Acquir Immune Defic Syndr 2006, 43(2):179-185. 10.1097/01.qai.0000242447.82403.c2 16940854
15. 3Cs4kids Analysis and Writing Committee Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: A meta-analysis Aids 2008, 22(1):97-105. 18090397
16. Bunders M Lugada E Mermin J Downing R Were W Thorne C Newell ML Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda Ann Trop Paediatr 2006, 26(3):169-179. 10.1179/ 146532806X120255 16925953
17. Dieye TN Vereecken C Diallo AA Ondoa P Diaw PA Camara M Karam F Mboup S Kestens L Absolute CD4 T-cell counting in resource-poor settings: Direct volumetric measurements versus bead-based clinical flow cytometry instruments J Acquir Immune Defic Syndr 2005, 39(1):32-37. 10.1097/ 01.qai.0000160515.20581.ad 15851911
18. Pattanapanyasat K Lerdwana S Noulsri E Chaowanachan T Wasinrapee P Sakulploy N Pobkeeree V Suksripanich O Thanprasertsuk S Spira TJ Evaluation of a new single-parameter volumetric flow cytometer (CyFlow(green)) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients Clin Diagn Lab Immunol 2005, 12(12):1416-1424. 10.1128/CDLI.12.12.1416-1424.2005 16339065 1317067
19. Violari A Cotton M Gibb D Babiker A Steyn J Jean-Phillip P McIntyre J Team obotCS Antiretroviral therapy initiated before 12 weeks of age reduces early mortality in young HIV-infected infants: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study [CDB0037] Presented at: 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention: 2007; Sydney, Australia 2007.
20. Puthanakit T Ananworanich J Kosalaraksa P Hansudewechakul R Chuenyam T Chettra K Saphonn V Chhi Vun M Cooper D Fox L A randomized trial of early versus deferred initiation of antiretroviral therapy (ART) in HIV-infected children with moderate immune suppression in Cambodia and Thailand: The PREDICT study [CDB225] Presented at: 4th IAS conference on HIV Pathogenesis, Treatment and Prevention: 2007; Sydney, Australia 2007.